# Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old

> **NCT04748601** · PHASE4 · RECRUITING · sponsor: **Upsher-Smith Laboratories** · enrollment: 132 (estimated)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Qudexy XR
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04748601
- **Lead sponsor:** Upsher-Smith Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-19
- **Primary completion:** 2026-09
- **Final completion:** 2026-09
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2025-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04748601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04748601, "Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04748601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*